Filter Search


Europe


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To §§ 130a Para. 8/130c Para. 1 Sgb V For Medicinal Products Containing The Active Ingredient Tadalafil (g04be08), Only Medicinal Products With The Indication Benign Prostate Syndrome Within The Fra 2026-12-31
Germany Brinzolamide/timolol_tk, Hek, Hkk 2026-12-31
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tiotropium Bromide (atc Code According To Who 2026-12-31
Germany Open House Original Discount Contracts 202412 Tofacitinib 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Iron(iii) Oxide-sucrose Complex (b03ac02) as Part Of A So-called Open-house Model. 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Norway Qualification For Participation In Contests For Passenger Transport On The Norwegian Railway Network 2026-12-31
Czech Republic Dynamic Purchasing System For Making Fve Feasibility Studies 2026-12-31
Germany Doxycycline (immediate-release Oral Drf; Excluding 100 Mg, 200 Mg)_tk, Hek, Hkk 2026-12-31
Slovenia Dynamic Purchasing System For Purchasing Promotional Material 2026-12-31
Whats app